Factors that predict changing the type of phosphodiesterase type 5 inhibitor medication among men in the UK
Philip D. Kell, Kyle Hvidsten, Steven V. Morant, James P. Harnett, Sarah BridgeVolume:
99
Year:
2007
Language:
english
Pages:
4
DOI:
10.1111/j.1464-410x.2006.06668.x
File:
PDF, 90 KB
english, 2007